Pacira BioSciences

PCRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$997.344 M

$25.02 -2.19%

Close of 7 Aug 2026

Revenue

$726.4M

#1719 by revenue

Earnings

$7.00M

#2132 by earnings

Shares outstanding

39,861,886

Latest filing cover page

P/E ratio

142.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#159ApnimedAPMD$1.03B
#160Opko HealthOPK$1.02B
#161Pacira BioSciencesPCRX$997.3M
#162ArdelyxARDX$988.1M
#163Avalo TherapeuticsAVTX$969.2M

Where these numbers come from

Share counts and financials for Pacira BioSciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.